# PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

> **NCT01737619** · NA · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 101 (actual)

## Conditions studied

- Endometrial Clear Cell Adenocarcinoma
- Endometrial Mixed Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Grade 3 Endometrial Endometrioid Adenocarcinoma
- Malignant Mixed Mesodermal (Mullerian) Tumor

## Interventions

- **PROCEDURE:** Computed Tomography
- **DRUG:** Indocyanine Green Solution
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Lymph Node Mapping
- **PROCEDURE:** Lymphadenectomy
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT01737619
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-04-03
- **Primary completion:** 2025-04-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737619, "PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01737619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*